• Groundbreaking Malaria Vaccine and Treatment Breakthroughs Offer New Hope

  • Apr 16 2025
  • Length: 3 mins
  • Podcast

Groundbreaking Malaria Vaccine and Treatment Breakthroughs Offer New Hope

Listen for free

View show details

  • Summary

  • In recent developments, the fight against malaria has seen significant advancements, particularly with the malaria vaccine and new treatment discoveries.

    In Kenya's lake region, the implementation of the malaria vaccine has yielded promising results. Since 2019, when Kenya became one of the first countries to participate in the Malaria Vaccine Implementation Programme (MVIP), the vaccine has been instrumental in reducing malaria-related mortality and disease severity among children. According to Ochieng Gumbo, the Lake Region Economic Block (LREB) Health Pillar lead, the vaccine, combined with other existing malaria interventions, has led to a noticeable drop in all-cause mortality among children. Hospital statistics show a reduced prevalence of severe malaria cases, with vaccinated children having higher chances of survival even if they contract the disease[5].

    The vaccine's success is also attributed to the community health promoters who have been crucial in creating demand and ensuring timely vaccinations. Edith Anjere, the Vihiga County Expanded Programme on Immunization Coordinator, noted that vaccine acceptance has improved significantly over time, and the county is now working to ensure a steady supply of the vaccine to protect the entire eligible population[5].

    Apart from vaccination efforts, researchers are also making strides in developing new treatments to combat malaria. A recent study by scientists at the Geisel School of Medicine at Dartmouth College and the Canadian Light Source at the University of Saskatchewan has identified a compound, IMP-1088, that targets the malaria-causing parasite *Plasmodium vivax*. This compound binds to an enzyme called N-myristoyltransferase (NMT), which is essential for the parasite's lifecycle. The advantage of this approach is that some NMT inhibitors have already been tested for other diseases, potentially reducing toxicity and development costs[1].

    Another breakthrough comes from researchers at Case Western Reserve University School of Medicine, who have discovered a new target for fighting drug-resistant malaria. The team found that a cholesterol-managing protein called PfNCR1 is crucial for the survival of the *Plasmodium falciparum* parasite. By using a compound known as MMV009108 to block this protein, the researchers aim to disrupt the parasite's ability to control its cholesterol levels, potentially leading to its death. This discovery is seen as a significant step forward in developing new malaria treatments that the parasite may find difficult to develop resistance to[2].

    As the global community marks World Malaria Day on April 25, 2025, under the theme "Malaria Ends with Us: Reinvest, Reimagine, Reignite," there is a renewed call to action to accelerate progress towards malaria elimination. The World Health Organization emphasizes the need to reinvest in proven interventions, reimagine strategies to overcome current obstacles, and reignite collective efforts to end malaria. Despite progress in reducing cases and deaths over the past few decades, recent challenges such as extreme weather events, conflict, and economic stresses have stalled progress, highlighting the urgency of continued efforts[3].
    Show More Show Less
Show More Show Less

What listeners say about Groundbreaking Malaria Vaccine and Treatment Breakthroughs Offer New Hope

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available